# Bolt Biotherapeutics Inc. (BOLT)

Source: https://www.quantisnow.com/company/BOLT
Generated: 2026-11-04T16:57:43.376Z

- Ticker: BOLT
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- SEC CIK: 0001641281
- Website: boltbio.com

## About

Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; and BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.

## Latest BOLT news and filings

- 2026-11-03 13:00 UTC [Conference Announcement] [Bolt Biotherapeutics to Participate in Upcoming Conferences](https://www.quantisnow.com/insight/bolt-biotherapeutics-to-participate-in-upcoming-conferences-6768493)
- 2026-10-27 21:21 UTC [SEC Form 4] [SEC Form 4 filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-bolt-biotherapeutics-inc-6759735)
- 2026-10-27 21:20 UTC [SEC Form 3] [SEC Form 3 filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-bolt-biotherapeutics-inc-6759732)
- 2026-10-23 14:31 UTC [SEC Form 8-K] [SEC Form 8-K filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-bolt-biotherapeutics-inc-6756054)
- 2026-10-23 13:08 UTC [Earnings Date] [Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications](https://www.quantisnow.com/insight/bolt-biotherapeutics-announces-acquisition-of-prana-therapies-and-120-million-6755995)
- 2026-10-06 20:07 UTC [SEC Form 8-K] [SEC Form 8-K filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-bolt-biotherapeutics-inc-6738910)
- 2026-09-21 22:03 UTC [Insider Buy] [President, CEO and CFO Quinn William P. bought $2,469 worth of shares (637 units at $3.88) and sold $58,402 worth of shares (17,566 units at $3.32), increasing direct ownership by 997% to 25,384 units (SEC Form 4) to satisfy withholding tax](https://www.quantisnow.com/insight/president-ceo-and-cfo-quinn-william-p-bought-2469-worth-6722097)
- 2026-09-21 22:04 UTC [Insider Buy] [Senior VP, Finance and PAO Nemec Sarah bought $1,973 worth of shares (509 units at $3.88) and sold $26,072 worth of shares (7,842 units at $3.32), increasing direct ownership by 1,107% to 17,082 units (SEC Form 4) to satisfy withholding tax](https://www.quantisnow.com/insight/senior-vp-finance-and-pao-nemec-sarah-bought-1973-worth-6722094)
- 2026-09-21 22:05 UTC [SEC Form 4] [Chief Operating Officer Yonehiro Grant sold $43,807 worth of shares (13,176 units at $3.32), decreasing direct ownership by 43% to 17,269 units (SEC Form 4) to satisfy tax liability](https://www.quantisnow.com/insight/chief-operating-officer-yonehiro-grant-sold-43807-worth-of-shares-6722093)
- 2026-08-13 20:20 UTC [SEC Form SCHEDULE 13G filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-bolt-biotherapeutics-inc-6680738)
- 2026-08-11 20:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bolt-biotherapeutics-inc-6675746)
- 2026-08-11 20:05 UTC [SEC Form 8-K] [Bolt Biotherapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bolt-biotherapeutics-inc-filed-sec-form-8-k-results-of-operations-6675688)
- 2026-08-11 20:05 UTC [Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/bolt-biotherapeutics-reports-second-quarter-2026-financial-results-and-provides-6675651)
- 2026-05-29 12:11 UTC [Analyst Coverage Initiated] [Rodman & Renshaw initiated coverage on Bolt Biotherapeutics with a new price target](https://www.quantisnow.com/insight/rodman-renshaw-initiated-coverage-on-bolt-biotherapeutics-with-a-new-6578437)
- 2026-05-12 20:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bolt-biotherapeutics-inc-6547991)
- 2026-05-12 20:05 UTC [SEC Form 8-K] [Bolt Biotherapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bolt-biotherapeutics-inc-filed-sec-form-8-k-results-of-operations-6547925)
- 2026-05-12 20:05 UTC [Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/bolt-biotherapeutics-reports-first-quarter-2026-financial-results-and-provides-6547861)
- 2026-04-28 20:06 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-bolt-biotherapeutics-inc-6518544)
- 2026-04-28 20:05 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-bolt-biotherapeutics-inc-6518527)
- 2026-03-12 20:14 UTC [SEC Form S-8] [SEC Form S-8 filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-bolt-biotherapeutics-inc-6444638)
- 2026-03-12 20:07 UTC [SEC Form 10-K] [SEC Form 10-K filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-bolt-biotherapeutics-inc-6444459)
- 2026-03-12 20:05 UTC [SEC Form 8-K] [Bolt Biotherapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bolt-biotherapeutics-inc-filed-sec-form-8-k-results-of-operations-6444389)
- 2026-03-12 20:05 UTC [Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/bolt-biotherapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-6444293)
- 2026-02-24 13:00 UTC [Conference Announcement] [Bolt Biotherapeutics to Participate in Upcoming March Conferences](https://www.quantisnow.com/insight/bolt-biotherapeutics-to-participate-in-upcoming-march-conferences-6408937)
- 2026-02-04 21:32 UTC [Insider Buy] [President, CEO and CFO Quinn William P. bought $576 worth of shares (125 units at $4.61), increasing direct ownership by 6% to 2,313 units (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-and-cfo-quinn-william-p-bought-576-worth-6375577)
- 2026-02-04 21:32 UTC [SEC Form 4] [SEC Form 4 filed by Chief Operating Officer Yonehiro Grant](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-operating-officer-yonehiro-grant-6375571)
- 2026-02-04 21:32 UTC [Insider Buy] [Senior VP, Finance and PAO Nemec Sarah bought $576 worth of shares (125 units at $4.61), increasing direct ownership by 10% to 1,415 units (SEC Form 4)](https://www.quantisnow.com/insight/senior-vp-finance-and-pao-nemec-sarah-bought-576-worth-6375568)
- 2025-12-16 22:15 UTC [SEC Form 4] [SEC Form 4 filed by Director Dupont Jakob](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-dupont-jakob-6318532)
- 2025-12-16 22:14 UTC [SEC Form 4] [SEC Form 4 filed by Director Onetto Nicole](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-onetto-nicole-6318530)
- 2025-12-16 22:14 UTC [SEC Form 4] [SEC Form 4 filed by Director Berner Laura](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-berner-laura-6318526)
- 2025-12-16 22:13 UTC [SEC Form 4] [SEC Form 4 filed by Director Laporte Kathleen](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-laporte-kathleen-6318525)
- 2025-12-16 22:13 UTC [SEC Form 4] [SEC Form 4 filed by Director O'Callaghan Brian](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-ocallaghan-brian-6318522)
- 2025-12-16 22:12 UTC [SEC Form 4] [SEC Form 4 filed by Senior VP, Finance and PAO Nemec Sarah](https://www.quantisnow.com/insight/sec-form-4-filed-by-senior-vp-finance-and-pao-6318520)
- 2025-12-16 22:11 UTC [SEC Form 4] [SEC Form 4 filed by Chief Operating Officer Yonehiro Grant](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-operating-officer-yonehiro-grant-6318514)
- 2025-12-16 22:11 UTC [SEC Form 4] [SEC Form 4 filed by President, CEO and CFO Quinn William P.](https://www.quantisnow.com/insight/sec-form-4-filed-by-president-ceo-and-cfo-quinn-6318510)
- 2025-11-14 21:17 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-bolt-biotherapeutics-inc-6280694)
- 2025-11-14 21:15 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-bolt-biotherapeutics-inc-6280628)
- 2025-11-12 21:08 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Bolt Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bolt-biotherapeutics-inc-6274430)
- 2025-11-12 21:05 UTC [SEC Form 8-K] [Bolt Biotherapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bolt-biotherapeutics-inc-filed-sec-form-8-k-results-of-operations-6274354)
- 2025-11-12 21:05 UTC [Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/bolt-biotherapeutics-reports-third-quarter-2025-financial-results-and-provides-6274250)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BOLT
- Earnings history: https://www.quantisnow.com/earnings/BOLT
- Dividend history: https://www.quantisnow.com/dividends/BOLT
- Insider transactions: https://www.quantisnow.com/insiders/BOLT
- Options chain: https://www.quantisnow.com/options/BOLT
- SEC 8-K filings only: https://www.quantisnow.com/company/BOLT/8-k
- RSS and alerts for BOLT: https://www.quantisnow.com/docs/rss-feeds.md